NuCana plc
NCNA
$3.40
-$0.04-1.16%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/21/2025
-
Ticker Report
8/20/2025
-
GuruFocus
8/20/2025
-
GuruFocus
8/20/2025
-
Globe Newswire
8/8/2025
-
The Fly
8/2/2025
-
Ticker Report
8/1/2025
-
GuruFocus
8/1/2025
-
TipRanks Financial Blog
8/1/2025
-
GuruFocus
8/1/2025
-
GuruFocus
8/1/2025
-
TipRanks Financial Blog
8/1/2025
-
The Fly
8/1/2025
-
Globe Newswire
7/21/2025
-
GuruFocus
7/21/2025
-
GuruFocus
7/21/2025
-
GuruFocus
7/21/2025
-
The Fly
7/21/2025
-
Globe Newswire
7/11/2025
-
GuruFocus
7/11/2025
-
TipRanks Financial Blog
7/11/2025
-
GuruFocus
7/11/2025
-
Globe Newswire
6/27/2025
-
TipRanks Financial Blog
6/20/2025
-
TipRanks Financial Blog
6/16/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 20, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 13 1357 1111
Address
3 Lochside Way
Edinburgh, EH12 9DT
Edinburgh, EH12 9DT
Country
Year Founded
Business Description
Sector
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed...
more